التفاصيل البيبلوغرافية
| العنوان: |
Secretagogin is increased in plasma from type 2 diabetes patients and potentially reflects stress and islet dysfunction. |
| المؤلفون: |
Hansson, Sara F., Zhou, Alex-Xianghua, Vachet, Paulina, Eriksson, Jan W., Pereira, Maria J., Skrtic, Stanko, Jongsma Wallin, Helen, Ericsson-Dahlstrand, Anders, Karlsson, Daniel, Ahnmark, Andrea, Sörhede Winzell, Maria, Magnone, Maria Chiara, Davidsson, Pia |
| المصدر: |
PLoS ONE; 4/27/2018, Vol. 13 Issue 4, p1-23, 23p |
| مصطلحات موضوعية: |
GHRELIN receptors, BLOOD plasma, TYPE 2 diabetes, DISEASE progression, ENDOCRINE diseases |
| مستخلص: |
Beta cell dysfunction accompanies and drives the progression of type 2 diabetes mellitus (T2D), but there are few clinical biomarkers available to assess islet cell stress in humans. Secretagogin, a protein enriched in pancreatic islets, demonstrates protective effects on beta cell function in animals. However, its potential as a circulating biomarker released from human beta cells and islets has not been studied. In this study primary human islets, beta cells and plasma samples were used to explore secretion and expression of secretagogin in relation to the T2D pathology. Secretagogin was abundantly and specifically expressed and secreted from human islets. Furthermore, T2D patients had an elevated plasma level of secretagogin compared with matched healthy controls, which was confirmed in plasma of diabetic mice transplanted with human islets. Additionally, the plasma secretagogin level of the human cohort had an inverse correlation to clinical assessments of beta cell function. To explore the mechanism of secretagogin release in vitro, human beta cells (EndoC-βH1) were exposed to elevated glucose or cellular stress-inducing agents. Secretagogin was not released in parallel with glucose stimulated insulin release, but was markedly elevated in response to endoplasmic reticulum stressors and cytokines. These findings indicate that secretagogin is a potential novel biomarker, reflecting stress and islet cell dysfunction in T2D patients. [ABSTRACT FROM AUTHOR] |
|
Copyright of PLoS ONE is the property of Public Library of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder